Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Studies measuring patient preference stacked up in subcutaneous administration’s favor, according to a recently published ...

The results showed that 26% of patients who received tulisokibart achieved clinical remission at week 12 compared with 1% of ...

As the global population ages, respiratory viral infections have become a significant health concern, leading to severe ...

The higher dose led to a more rapid decline in an important marker of neurodegeneration, according to a Biogen news release ...

Sanjula Jain of Trilliant Health talks about how employers are best positioned to demand value for money from the U.S.

A review of skeletal muscle relaxants shows that they don't work for pain from osteoarthritis, neuropathic pain and other ...

People living with HIV in neighborhoods that had been redlined by federal housing officials had a longer time interval ...

More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...

Arwen Podesta, M.D., discussed prescription digital therapeutics for people with mental health and substance abuse conditions ...

Early trial data of two virally suppressed, breast-feeding women with HIV shows that there may be less of a risk of HIV ...